Analytical techniques for furosemide determination

Separation and Purification Reviews

Volumn 35, Issue 2, 2006, Pages 39-58

  Ruiz Angel, María José ^a   Berthod, Alain ^a   Carda Broch, Samuel ^b   García Álvarez Coque, María Celia ^c  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITAT JAUME I   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Furosemide; Pharmaceutical and biological samples; Purification; Separation procedures; Stability

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; ELECTROPHORESIS; PURIFICATION; SAMPLING; SEPARATION; STABILITY;

BIOLOGICAL SAMPLES; CAPILLARY ELECTROPHORESIS; FUROSEMIDE; PHARMACEUTICAL SAMPLES;

DRUG PRODUCTS;

EID: 33750084417     PISSN: 15422119     EISSN: 15422127     Source Type: Journal    
DOI: 10.1080/15422110600671726     Document Type: Article

References (103)

1. Delgado, J.N. and Remers, W.A. eds.; (1991) Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, 9th ed.; J.B. Lippincot: Philadelphia, PA.
2. Foye, W.O., Lemke, T.L., and Williams, D.A. (1995) Principles of Medicinal Chemistry, 4th ed.; Williams and Wilkins: Philadelphia, PA, 405.
3. Shinto, R.A. and Light, R.W. (1990) Effects of diuresis on the characteristics of pleural fluid in patients with congestive heart failure. Am. J. Med., 88: 230-234.
4. Modell, W. ed.; (1984) Drugs of Choice; C.V. Mosby: Toronto.
5. Reynolds, E.F. ed.; (1982) Martindale: The Extra Pharmacopoeia, 28th ed.; The Pharmaceutical Press: London.
6. Leary, W.P. and Asmal, A.C. (1980) Slow release of furosemide in the treatment of mild to moderate hypertension. Curr. Ther. Res. Clin. Exp., 28: 549-553.
7. Kristensen, B.O. and Show, J. (1980) Captopril or furosemide in drug resistant hypertension. Lancet, 2: 699-700.
8. Ventura, R. and Segura, J. (1996) Detection of diuretic agents in doping control. J. Chromatogr. B, 687: 127-144.
9. International Olympic Committee. Medical Commission, International Olympic Chaner against Doping in Sport, IOC. Lausanne, 1990.
10. Sierra-Johnson, J. (2002) Inhaled furosemide: A whole new mechanism of action. Medical Hypotheses, 58: 529-530.
11. Benet, L.Z. (1979) Pharmacokinetics/pharmacodynamics of furosemide in man: A review. J. Phamacokinet. Biopharm., 7: 1-27.
12. Cutler, R.E. and Blair, A.D. (1979) Clinical pharmacokinetics of furosemide. Clin. Pharmacokinet, 4: 279-296.
13. Hammarlund-Udenaes, M. and Benet, L.Z. (1989) Furosemide pharmacokinetics and pharmacodynamics in health and disease-An update. J. Pharmacokinet. Biopharm., 17: 1-46.
14. Ponto, L.L. and Schoenwald, R.D. (1990) Furosemide: Pharmacokinetics/ pharmacodynamics review. Clin. Pharmacokinet, 18: 461-471.
15. DuSouich, P., Proulux, M., and Perreault, S. (1992) Pharmacokinetics of furosemide in healthy man. Prog. Pharmacol. Clin. Pharmacol., 9: 147-170.
16. Vergin, H., Mahr, G., Metz, R., Eichinger, A., and Nitsche, V. (1998) Investigation on the bioequivalence of two oral preparations Containing Spironolactone and Furosemide. Int. J. Clin. Pharmacol. Therapeut., 36: 231-238.
17. Moffat, A.C. (1986) Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Post-Mortem Material, 2nd ed.; Pharmaceutical Press: London.
18. Sekikawa, H., Yagi, N., Oda, K., Kenmotsu, H., Takada, M., Chen, H., Lin, E.T., and Benet, L.Z. (1995) Biliary excretion of furosemide glucuronide in rabbits. Biol. Pharm. Bull., 18: 447-453.
19. Chungi, V.S., Dittert, L.W., and Smith, R.B. (1979) Gastrointestinal Sites of Furosemide Absorption in Rats. Int. J. Pharm., 4: 27-38.
20. Lee, M.G. and Chiou, W.L. (1983) Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J. Pharmacokinet. Biopharm., 11: 623-640.
21. British Pharmacopoeia (1998) Her Majesty's Stationary Office: London, 624, 1700, 1103, 1904.
22. United States Pharmacopoeial Convention, Inc. (2000) USP XXIV; National Publishing: Philadelphia, 756-1428.
23. García-Valdés, J., García-Hernández, G., and González-González, O.L. (1998) Purificación de Furosemida. In Sintefarma. www.bvs.sld.cu/revistas/sint/vol4_2_98/sint.2298.htm.
24. Hadjù, P. and Häussler, A. (1964) Untersuchungen mit dem salidiureticum 4-chlor-N(2-furylmethyl)-5-sulfamyl-antranilsäure. Arzneimittel-Forsch., 14: 709-710.
25. Häussler, A. and Wicha, H. (1965) Untersuchungen mit dem salidiureticum 4-chlor-N(2-furylmethyl)-5-sulfamyl-antranilsäure. Arzneimittel-Forsch., 15: 81-83.
26. Pérez, J., Sitar, D.S., and Optivi, R.I. (1980) Kinetic disposition and diuretic effect of furosemide in acute pulmonary oedema. Br. J. Clin. Pharmac., 9: 471-478.
27. Andreasen, F., Botker, H.E., and Lorentzen, K. (1982) In vitro studies on the hydrolysis of furosemide in gastrointestinal juices. Br. J. Clin. Pharmac., 14: 306-309.
28. Beerman, B., Dalén, E., Lindström, B., and Rosén, A. (1975) On the fate of furosemide in man. Europ. J. Clin. Pharmacol., 9: 57-61.
29. Smith, D.E., Lin, E.T., and Benet, L.Z. (1980) Absorption and disposition of furosemide in healthy volunteers; Measure with a metabolite specific assay. Drug. Metab. Dispos., 8: 337-342.
30. Aranda, J.V., Lambert, C., Pérez, J., Turmen, D., and Sitar, D.S. (1982) Metabolism and renal elimination of furosemide in the newborn infant. J. Pediatr., 101: 777-781.
31. Rachmel, A., Hazelton, G.H., Yergey, A.L., and Liberato, D.J. (1985) Furosemide 1-O-acyl glucuronide in vitro biosynthesis and pH-dependent isomerisation to beta-glucuronidase-resistant forms. Drug Metab. Dispos., 13: 705-710.
32. Sweetman, S.C. (ed.) (2002) Martindale: The Complete Drug Reference, 33rd ed.; Pharmaceutical Press: London, 986-987.
33. Moore, D.E. (2002) Drug induced cutaneous photosensitivity: Mechanism, prevention and management. Drug Saf., 25: 345-372.
34. Vargas, F., Martínez-Volkmar, I., Sequera, J., Méndez, H., Rojas, J., Fraile, G., Velasquez, M., and Medina, R. (1998) Photodegradation and phototoxicity studies of furosemide. Involvement of singlet oxygen in the photoinduced hemolysis and lipid peroxidation. J. Photochem. Photobiol. B, 42: 219-225.
35. Selvaag, E. and Thume, P. (1996) Photodegradation products of sulfonamidederived oral antidiabetics and diuretics are not phototoxic in vitro. Photodermatol. Photoimmunol. Photomed., 12: 79-83.
36. Bundgaard, H., Nogaard, T., and Nielsen, N.M. (1988) Photodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutions. Int. J. Pharm., 42: 217-224.
37. Asker, A.F. and Ferdous, A.J. (1996) Photodegradation of furosemide solutions. PDA J. Pharm. Sci. Technol., 50: 158-162.
38. Sturm, K., Siedel, W., Weyer, R., and Rusching, R. (1966) Chemistry of furosemide I. Synthesis of 5-sulfamoylanthranilic acid derivatives. Chem. Ber., 99: 328-344.
39. Kovar, K.A., Wojtovicz, G.P., and Auterhoff, H. (1974) Hydrolysis of diuretic sulfonamides. Arch. Pharm. Weinheim. Ger., 307: 657-662.
40. Ghanekar, A.G., Gupta, V.D., and Gibss, C.W. (1978) Stability of furosemide in aqueous systems. J. Pharm. Sci., 67: 808-811.
41. Shah, K.A., Gupta, V.D., and Stewart, K.R. (1980) Effect of pH, chlorobutanol, cysteine hydrochloride, ethylenediaminetetraacetic acid, propylene glycol, sodium metabisulfite, and sodium sulfite on furosemide stability in aqueous solutions. J. Pharm. Sci., 69: 594-596.
42. Rowbotham, P.C., Stanford, J.B., and Sugden, J.K. (1976) Some aspects of the photochemical degradation of furosemide. Pharm. Acta Helv., 51: 304-307.
43. Moore, D.E. and Tamat, S.R. (1980) Photosensitisation by drugs: Photolysis of some chlorine-containing drugs. J. Pharm. Pharmacol., 32: 172-177.
44. Moore, D.E. and Sithipitaks, V. (1983) Photolytic degradation of furosemide. J. Pharm. Pharmacol., 35: 489-493.
45. Hanna, G.M. and Lau-Cam, C.A. (1993) Stability-indicating proton nuclear magnetic resonance spectroscopic assay method for furosemide in tablets and injections. JAOAC Int., 76: 526-530.
46. Carda-Broch, S., Esteve-Romero, J., and García-Alvarez-Coque, M.C. (2000) Furosemide assay in pharmaceutical s by micellar liquid chromatography: Study of the stability of the drug. J. Pharm. Biomed. Anal., 23: 803-817.
47. Guzmán, A., Agüí, L., Pedrero, M., Yánez-Sedeño, P., and Pingarrón, J.M. (2003) Flow injection and HPLC determination of furosemide using pulsed amperometric detection at microelectrodes. J. Pharm. Biomed. Anal., 33: 923-933.
48. Carda-Broch, S., Esteve-Romero, J., Ruiz-Angel, M.J., and García-Alvarez-Coque, M.C. (2002) Determination of furosemide in urine samples by direct injection in a micellar liquid chromatographic system. Analyst, 127: 29-34.
49. Fiori, J., Ballardini, R., Andrisano, V., and Cavrini, V. (2003) Photostability studies on the furosemide-triamterene drug association. Il Farmaco, 58: 867-873.
50. Sekikawa, H., Yagi, N., Lin, E.T., and Benet, L.Z. (1995) Apparent intramolecular acyl migration and hydrolysis of furosemide glucuronide in aqueous solution. Biol. Pharm. Bull., 18: 134-139.
51. Issopoulos, P.B. (1989) Spectrophotometric determination of microquantities of furosemide using iso- and heteropolyanions of molybdenum(VI) as oxidizing agents. Fresenius'Z. Anal. Chem., 334: 554-557.
52. Zivanovic, L., Agatonovic, S., and Radulovic, D. (1990) Spectrophotometric determination of furosemide as its iron(III) complex in pharmaceutical preparations. Mikrochim. Acta, 1: 49-54.
53. Sastry, C.S.P., Prasad, T.N.V., Sastry, B.S., and Rao, E.V. (1988) Spectrophotometric methods for the determination of some diuretics using 3-methyl-2-benzothiazolinone hydrazone. Analyst, 113: 225-258.
54. Sevillano-Cabeza, A., Campins-Falcó, P., and Serrador- García, M.C. (1997) Extractive-spectrophotometric determination of furosemide with sodium 1,2-naphthoquinone-4-sulfonate in pharmaceutical formulations. Anal. Lett., 30: 91-107.
55. García-Sánchez, F., Fernández-Gutiérrez, A., and Cruces-Blanco, C. (1995) Variable-angle scanning fluorescence spectrometry for the simultaneous determination of three diuretic drugs. Anal. Chim. Acta, 306: 313-321.
56. Ferraro, M., Castellano, P., and Kaufman, T. (2001) A spectrophotometric-partial least squares (PLS-1) method for the simultaneous determination of furosemide and amiloride hydrochloride in pharmaceutical formulations. J. Pharm. Biomed. Anal., 26: 443-451.
57. Luis, M.L., Fraga, J.M.G., Jiménez, A.I., Jiménez, F., Hernández, O., and Arias, J.J. (2004) Application of PLS regression to fluorimetric data for the determination of furosemide and triamterene in pharmaceutical preparations and triamterene in urine. Talanta, 62: 307-316.
58. Toral, M.I., Pope, S., Quintanilla, S., and Ritcher, P. (2002) Simultaneous determination of amiloride and furosemide in pharmaceutical formulations by first digital derivative spectrophotometry. Int. J. Pharm., 249: 117-126.
59. Millership, J.S., Parker, C., and Donnelly, D. (2005) Ratio spectra derivative spectrophotometry for the determination of furosemide and spironolactone in a capsule formulation. Il Farmaco, 60: 333-338.
60. Wendlant, W.W. and Hecht, H.G. (1996) Reflectance Spectroscopy; Interscience Publishers: New York, 297.
61. Kealey, D. (1972) Quantitative reflectometry. I. Principles and scope. Talanta, 19: 1563-1571.
62. Gotardo, M.A., Gigante, A.C., Pezza, L., and Pezza, H.R. (2004) Determination of furosemide in pharmaceutical formulations by diffuse reflectance spectroscopy. Talanta, 64: 361 -365.
63. United States Pharmacopeia XXII, Supplement I. United States Pharmacopeial Convention: Rockville, MD, (1990).
64. Blair, A.D., Forrey, A.W., Meijsen, B.T., and Cutler, R.E. (1975) Assay of flucytosine and furosemide by high pressure liquid chromatography. J. Pharm. Sci., 54: 1334-1339.
65. MacGougall, M.L., Shoemar, D.W., and Azarnoff, D.L. (1975) Separation and quantitative analysis of furosemide and 4-chloro-5-sulfamoylanthranilic acid (CSA) by high pressure liquid chromatography. Res. Commun. Chem. Path. Phamacol., 10: 285-292.
66. Rapaka, R.S., Roth, J., and Prasad, V.K. (1982) Analysis of 4-chloro-5-sulfamoylanthranilic acid in the bulk material and pharmaceutical preparations of furosemide by a high performance liquid chromatographie method. Int. J. Pharm., 11: 237-247.
67. Abdel-Hamid, M. (2000) High performance liquid chromatography-mass spectrometric analysis of furosemide in plasma and its use in pharmacokinetic studies. Il Farmaco, 55: 448-454.
68. El-Saharty, Y.S. (2003) Simultaneous high performance liquid chromatography assay of furosemide and propranolol HCl and its application in a pharmacokinetic study, J. Pharm. Biomed. Anal., 33: 699-709.
69. Park, S.J., Pyo, H.S., Kim, Y.J., Kim, M.S., and Park, J. (1990) Systematic analysis of diuretic doping agents by HPLC screening and GC/MS confirmation. J. Anal. Toxicol., 14: 84-90.
70. Tsai, F.Y., Lui, L.F., and Chang, B. (1991) Analysis of diuretic doping agents by HPLC screening and GC-MSD confirmation. J. Pharm. Biomed. Anal., 9: 1069-1076.
71. Ventura, R., Nadal, T., Alcalde, P., Pascual, J.A., and Segura, J. (1993) Fast screening method for diuretics, probenecid and other compounds of doping interest. J. Chromatogr. A, 655: 233-242.
72. Campins, P., Herráez, R., and Sevillano, A. (1993) Improved detection limits for screening of diuretics by coupled liquid chromatography and ultraviolet-visible spectrophotometry. J. Chromatogr. B, 612: 245-251.
73. Campins-Falcó, P., Herráez-Hernández, R., and Sevillano-Cabeza, A. (1994) Column-switching techniques for screening of diuretics and probenecid in urine samples. Anal. Chem., 66: 244-248.
74. Roth, J., Rapaka, R.S., and Prasad, V.K. (1981) HPLC procedure for the analysis of furosemide in pharmaceuticals analysis of furosemide tablets and furosemide injections. Anal. Lett., 14: 1013-1030.
75. Carr, K., Rane, A., and Frölich, J.C. (1978) A simplified assay of furosemide in plasma and urine by high-pressure liquid chromatography. J. Chromatogr., 145:421-427.
76. De-Biase, V., Haskins, N., Organ, A., Betman, R., Giles, K., and Jarvis, S. (1999) High throughput liquid chromatography-mass spectrometric analysis using a novel multiplexed electrospray interface. Rapid. Commun. Mass. Spectrom., 13: 1165-1168.
77. Barroso, M.B., Alonso, R.M., and Jiménez, R.M. (1995) Electrochemical determination of the loop diuretics piretanide and furosemide in pharmaceutical formulations and urine. Anal. Chim. Acta, 305: 332-339.
78. Barroso, M.B., Alonso, R.M., Jiménez, R.M., and Ortiz, E. (1996) Determination of piretanide and furosemide in pharmaceutical s and human urine by high-performance liquid chromatography with amperometric detection, J. Chromatogr. 5, 675:303-312.
79. Mache, M. and Wintersteiger, J. (1995) Improved electrochemical detection of diuretics in high-performance liquid chromatographic analysis by post-column on-line photolysis. J Chromatogr. A, 709: 257-264.
80. Yakatan, G.J., Maness, D.D., Scholler, S., Novick, W.J., and Doluisio, J.T. (1976) Absorption, distribution, metabolism and excretion of furosemide in dogs and monkey I: Analytical methodology, metabolism and urinary excretion. J. Pharm. Sci., 65: 1456-1460.
81. Mikkelsen, E. and Andreasen, F. (1977) Simultaneous determination of furosemide and two of its possible metabolites in biological fluids. Acta Pharmacol. Toxicol., 41: 254-262.
82. Steiness, I.E., Christansen, J., and Steiness, E. (1979) Direct thin-layer densitometric determination of pharmacological concentrations of furosemide in plasma and urine. J. Chromatogr., 164: 241 -246.
83. Park, J., Park, S., Lho, D., Choo, H.P., Chung, B., Yoon, C., Min, H., and Choi, M.J. (1990) Drug testing at the 10th Asian games and 24th Seoul olympic games. J. Anal. Toxicol., 14: 66-72.
84. Chan, S.C., Torok-Both, G.A., Billay, D.M., Przybylski, P.S., and Gradeen, C.Y. (1991) Drug analysis at the 1988 Olympic winter games in Calgary. Clin. Chem., 37: 1289-1296.
85. Segura, J., Pascual, J.A., Ventura, R., Ustaran, J.I., Cuevas, A., and Gonzalez, R. (1993) International cooperation in analytical chemistry: Experience of antidoping control at the XI Pan American Games. Clin. Chem., 39: 836-845.
86. Schänzer, W., Belloti, P., Benzi, G., and Ljungqvist, A. (eds.) (1988) Proceedings of International Athletic Foundation World Symposium on Doping in Sport. International Athletic Foundation: Monte Carlo, Monaco, 89-106.
87. Saugy, M., Meuwly, P., Munafo, A., and Rivier, L. (1991) Rapid high-performance liquid chromatographic determination with fluorescence detection of furosemide in human body fluids and its confirmation by gas chromatography-mass spectrometry, J. Chromatogr., 564: 567-578.
88. Hagedorn, H.W. and Schulz, R. (1992) Detection of diuretics in horse urine by GC/MS. J. Anal. Toxicol., 16: 194-198.
89. Ehrhardt, J.D. (1992) Negative-ion mass spectra of methylated diuretics. Rapid Commun. Mass Spectrom., 6: 349-351.
90. Riekkola, M.L. and Jumppanen, J.H. (1996) Capillary electrophoresis of diuretics. J. Chromatogr. A, 735: 151-164.
91. Jumppanen, J., Sirén, H., and Riekkola, M.L. (1993) Screening for diuretics in urine and blood serum by capillary zone electrophoresis. J. Chromatogr. A, 652: 441 -450.
92. Sádecká, J. and Polonský, J. (1996) Determination of some cardiovascular drugs in serum and urine by capillary isotachophoresis. J. Chromatogr. A, 735: 403-408.
93. Lalljie, S.P.D., Barroso, M.B., Steenackers, D., Alonso, R.M., Jiménez, R.M., and Sandra, P. (1997) Micellar electrokinetic chromatography as a fast screening method for the determination of the doping agents furosemide and piretanide in urine. J. Chromatogr. B, 688: 71-78.
94. Luis, M.L., Corujedo, S., Blanco, D., Fraga, J.M.G., Jiménez, A.I., Jiménez, F., and Arias, J.J. (2002) Micellar electrokinetic capillary chromatography analysis of diuretics in pharmaceutical formulations. Talanta, 57: 223-231.
95. Soetebeer, U.B., Shierenberg, M.O., Möller, J.G., Shulz, H., Grunefeld, G., Andresen, P., and Blaschke, G. (2000) Capillary electrophoresis with laser-induced fluorescence in clinical drug development-routine application and future aspects. J. Chromatogr. A, 895: 147-155.
96. Zaugg, S., Zhang, X., Sweedler, J., and Thormann, W. (2001) Determination of salicylate, gentisic acid and salicyluric acid in human urine by capillary electrophoresis with laser-induced fluorescence detection. J. Chromatogr. B, 752: 17-31.
97. Ramseier, A., Siethoff, C., Caslavska, J., and Thormann, W. (2000) Confirmation testing of amphetamines and designer drugs in human urine by capillary electrophoresis-ion trap mass spectrometry. Electrophoresis, 21: 380-387.
98. Wey, A.B. and Thormann, W. (2001) Head-column field-amplified sample stacking in presence of siphoning: Application to capillary electrophoresis- electrospray ionization mass spectrometry of opioids in urine. J. Chromatogr. A, 924:507-518.
99. Caslavska, J. and Thormann, W. (2002) Rapid analysis of furosemide in human urine by capillary electrophoresis with laser-induced fluorescence and electrospray ionization-ion trap mass spectrometric detection. J. Chromatogr. B, 770: 207-216.
100. García, M.S., Sánchez-Pedreño, C., Albero, M.I., and Ródenas, V. (1997) Flowinjection spectrophotometric determination of furosemide or sulfathiazole in pharmaceuticals. J. Pharm. and Biomed. Anal., 15: 453-459.
101. Rao, Y., Zhang, X., Luo, G., and Baeyens, W.R.G. (1999) Chemiluminiscence flow-injection determination of furosemide based on a rhodamine 6G sensitized cerium(IV) method. Anal. Chim. Acta, 396: 273-277.
102. Huclová, J., Šatínský, D., Maia, T., Karlíček, R., Solich, P., and Nova-Araujo, A. (2005) Sequential injection extraction based on restricted access material for determination of furosemide in serum. J. Chromatogr. A, 1087: 245-251.
103. Shaik, B. (1995) Veterinary drug residues. In Food Safety ACS Symp., Ser. Vol. 636; American Chemical Society: Washington, DC, 161-179.